Replies to post #76942 on Biotech Values

[iwfal]

il-21 has to be considered a long shot

? You correctly corrected me on the prelim RCC data a while ago - that it was actually pretty good compared to historical data in 2nd line patients. (I consider historical data in first line very sceptically, but less so in 2nd line.) ?